CEACAM1 is known to be expressed on activated NK cells where it serves an inhibitory function by abrogating natural-killer group 2, member D (NKG2D)-signaling in response to NKG2D ligands expressed by tumor cells94,95. The gene discussed is CEACAM1; the disease is neoplasm.